MedTrace Logo

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

NCT05562635 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-07-21

No results posted yet for this study

Summary

The aim of the project is to assess the effectiveness of reducing the masseter muscles tension and hyperactivity in patients with a painful form of TMD by using polymers containing CBD compared to placebo polymers.

Conditions

  • Temporomandibular Disorder
  • Myofascial Pain
  • Orofacial Pain
  • CBD
  • Bruxism

Interventions

COMBINATION_PRODUCT

5% polymer gel with CBD application

Bilateral application of 5% polymer gel with CBD intraorally, on the masseter muscle

COMBINATION_PRODUCT

10% polymer gel with CBD application

Bilateral application of 10% polymer gel with CBD intraorally, on the masseter muscle

COMBINATION_PRODUCT

Placebo intervention

Application of placebo without CBD

Sponsors & Collaborators

  • Medical University of Silesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-18
Primary Completion
2023-07-30
Completion
2023-08-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05562635 on ClinicalTrials.gov